"Recent genomic studies illustrated molecular heterogeneity of DLBCL and delineated patients with distinct genetic subtypes.9,24 We propose a simplified 20-gene algorithm to select targeted agents for individualized therapy."
#Hematology #Lymphoma #DLCL

https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00320-3?rss=yes&utm_source=dlvr.it&utm_medium=twitter#secsectitle0090